Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001567619-23-004430 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | FDMT | Bizily Scott | Chief Legal, HR Off | M - OptEx | $6.49 | +1,875 | 4,357 | +76% | +$12.2K |
| D | 2023-03-03 | 2023-03-01 | FDMT | Bizily Scott | Chief Legal, HR Off | S - Sale+OE | $19.30 | -2,248 | 2,109 | -52% | -$43.4K |
| D | 2023-03-03 | 2023-03-01 | FDMT | Bizily Scott | Chief Legal, HR Off | M - OptEx | $0.00 | -1,875 | 20.2K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | M | A | 1,875 | $6.49 | 4,357 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-01 | S | D | 2,248 | $19.30 | 2,109 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-03-01 | M | D | 1,875 | $0.00 | 20,250 | D | $6.49 · — to 2032-06-17 | 1,875 Common Stock | (F2) The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of June 16, 2022 (the "Vesting Commencement Date") such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company. |